QI
FLGT icon

QS Investors’s Fulgent Genetics FLGT Stock Holding History

QS Investors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$600K Hold
6,500
– – 0.01% 668
2021
Q1 		$629K Sell
6,500
-6,601
-50% -$681K 0.01% 696
2020
Q4 		$683K Sell
13,101
-400
-3% -$16.7K 0.01% 639
2020
Q3 		$541K Sell
13,501
-53,004
-80% -$1.66M 0.01% 655
2020
Q2 		$1.06M Sell
66,505
-200
-0.3% -$3.06K 0.01% 703
2020
Q1 		$718K Hold
66,705
– – 0.01% 750
2019
Q4 		$834K Buy
+66,705
New +$793K 0.01% 818

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

QS Investors's FLGT Position: Q2 2021 in Review

QS Investors held its Fulgent Genetics (FLGT) position steady in Q2 2021 at 6,500 shares worth $600K. The position accounts for 0.01% of the portfolio, ranked #668.

QS Investors first reported a position in FLGT in Q4 2019 and has held it in 7 quarters since. The position peaked at $1.06M in Q2 2020. 254 funds tracked by Wall St. Rank hold FLGT as of Q2 2021.

  • QS Investors held 6,500 shares of Fulgent Genetics worth $600K as of Q2 2021.
  • QS Investors left its Fulgent Genetics share count unchanged in Q2 2021.
  • Fulgent Genetics made up 0.01% of QS Investors's portfolio in Q2 2021, its #668 holding.
  • QS Investors first reported a position in Fulgent Genetics in Q4 2019 and has held it in 7 quarters since.
  • QS Investors's Fulgent Genetics position peaked at $1.06M in Q2 2020.
  • 254 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.